| (in millions $) | 31 Jan 2025 | 30 Oct 2024 | 30 May 2024 | 2 Mar 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $147.75 | $106.07 | $182.61 | |
| Inventory | ||||
| Total current assets | $1535.67 | $1502.52 | $1541.55 | |
| Long term investments | ||||
| Property, plant & equipment | $45.44 | |||
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $1678.8 | $1648.57 | $1691.95 | |
| Current liabilities | ||||
| Accounts payable | $12.88 | $17.4 | $9.08 | |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $414.05 | $402.24 | $440.75 | |
| Long term debt | ||||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $444.87 | $436.99 | $478.95 | |
| Shareholders' equity | ||||
| Retained earnings | -$1048.66 | -$1022.2 | -$971.07 | |
| Other shareholder equity | -$0.02 | -$2.04 | -$0.39 | |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2025 | 2 Mar 2024 | 3 Mar 2023 | 3 Mar 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $182.61 | $162.37 | $126.81 | |
| Inventory | ||||
| Total current assets | $1541.55 | $1509 | $1532.59 | |
| Long term investments | ||||
| Property, plant & equipment | $45.44 | $37.15 | $31.32 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $1691.95 | $1628.34 | $1623.67 | |
| Current liabilities | ||||
| Accounts payable | $9.08 | $12.45 | $14.27 | |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $440.75 | $380.85 | $308.68 | |
| Long term debt | ||||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $478.95 | $422.99 | $341.38 | |
| Shareholders' equity | ||||
| Retained earnings | -$971.07 | -$780.4 | -$506.1 | |
| Other shareholder equity | -$0.39 | |||
| Total shareholder equity | ||||
| (in millions $) | 30 Oct 2025 | 31 Aug 2024 | 30 May 2024 | 2 Mar 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $165.14 | $160.58 | $155.78 | |
| Cost of revenue | ||||
| Gross Profit | $134.93 | $130.27 | $128.81 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $178.23 | $197.98 | $177.11 | |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $0.65 | $0.66 | $0.56 | |
| Interest expense | $17.75 | $17.21 | $17.11 | |
| Net income | ||||
| Net income | -$26.46 | -$51.13 | -$31.62 | |
| Income (for common shares) | ||||
| (in millions $) | 2 Mar 2024 | 3 Mar 2023 | 3 Mar 2022 | 3 Mar 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $583.14 | $475.9 | $320.77 | $211.85 |
| Cost of revenue | ||||
| Gross Profit | $474.44 | $388.9 | $257.33 | $170.8 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $721.52 | $686.2 | $546.64 | $254.81 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $1.04 | $1 | $0.99 | $0.26 |
| Interest expense | $65.16 | $26.4 | ||
| Net income | ||||
| Net income | -$190.67 | -$274.3 | -$290.14 | -$83.52 |
| Income (for common shares) | ||||
| (in millions $) | 31 Aug 2024 | 30 May 2024 | 2 Mar 2024 | 1 Dec 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $5.01 | -$198.42 | -$535.17 | -$548.07 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $9.22 | $1.6 | $23.3 | $12.9 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $33.81 | -$168.68 | -$522.72 | -$556.31 |
| (in millions $) | 2 Mar 2024 | 3 Mar 2023 | 3 Mar 2022 | 3 Mar 2021 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$535.17 | -$9 | -$6.6 | $22.78 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $23.3 | $21.98 | $1147.85 | $177.12 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$522.72 | -$71.48 | $1085.03 | $160.28 |
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |